RxDoctor Payments Data

Leslie Sizemore, MD

Family Medicine · Pooler, GANPI 1356608723

Payments from drug & device makers

$11,289in general payments, 2019–2025

Across 723 payments — averaging $15.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Lilly USA, LLC$1K
  • AbbVie$1K
  • AstraZeneca$941
  • Pfizer$927
  • Astellas Pharma US Inc$389
  • plus $5K from 53 others

What the payments were for

  • Food & beverage$11,277100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk138$1,840
Lilly USA, LLC87$1,126
AbbVie(2 entities)73$1,076
AstraZeneca(2 entities)59$941
Pfizer60$927
Astellas Pharma US Inc20$389
Novartis23$374
Amgen20$327
Otsuka America Pharmaceutical, Inc.15$286
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$259
Boehringer Ingelheim15$238
Sanofi-aventis U.S. LLC14$214
Esperion Therapeutics, Inc.14$213
Abbott10$192
Merck13$189
Amarin Pharma, Inc.10$167
Axsome Therapeutics, Inc.7$163
Takeda Pharmaceuticals U.S.A., Inc.9$162
Johnson & Johnson9$155
Exact Sciences10$151
Bayer9$146
Antares Pharma, Inc.7$130
Dexcom, Inc.8$119
Mannkind Corporation4$117
GSK7$105
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$99
Medical Device Business Services, Inc.1$87
Boston Scientific4$83
Idorsia Pharmaceuticals US Inc4$74
Corium, LLC3$66
Xeris Pharmaceuticals, Inc.3$66
Halozyme Inc3$65
Sanofi Pasteur Inc.3$59
IBSA Pharma Inc.1$58
Harmony Biosciences LLC2$55
Phathom Pharmaceuticals, Inc.4$55
Kowa Pharmaceuticals America, Inc.4$50
Teva Pharmaceuticals USA, Inc.3$42
Genentech USA, Inc.2$39
Ironshore Pharmaceuticals Inc.2$38
Biohaven Pharmaceuticals, Inc.2$35
Lundbeck LLC2$31
Biohaven Pharmaceutical Holding Company Ltd.1$24
Aytu Biopharma, Inc.2$23
Biogen1$22
Nestle Healthcare Nutrition Inc.1$21
Sumitomo Pharma America, Inc.1$18
Bausch Health US, LLC1$17
Upsher-smith Laboratories LLC1$16
Shield Therapeutics Inc1$16
VBI Vaccine (delaware) Inc.1$15
Eisai Inc.1$15
Nalpropion Pharmaceuticals LLC1$15
Smith+Nephew1$14
Paratek Pharmaceuticals, Inc.1$13
Metuchen Pharmaceuticals1$13
Arbor Pharmaceuticals, Inc.1$13
Nevro Corp.1$13
Jazz Pharmaceuticals Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,289 in reported general payments places this provider in the 95th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$135,406
Medicare patients
266
Services billed
3,920

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin110$141,772
OzempicSemaglutide62$99,639
JanuviaSitagliptin Phosphate50$59,299
MounjaroTirzepatide45$55,045
TrulicityDulaglutide52$54,165
Dupixent SyringeDupilumab12$44,904
FarxigaDapagliflozin Propanediol39$44,762
EliquisApixaban29$42,956
LinzessLinaclotide30$28,166
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$27,889
MyrbetriqMirabegron13$15,650
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$9,656
EntrestoSacubitril/Valsartan13$7,963
Gabapentin206$4,061
Rosuvastatin Calcium328$3,883

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$238$141,772110 claims
Lilly USA, LLCMounjaro, Trulicity$1,126$109,21097 claims
Novo NordiskOzempic$1,840$99,63962 claims
MerckJanuvia$189$59,29950 claims
AstraZenecaFarxiga, Breztri Aerosphere$941$54,41854 claims
PfizerEliquis$927$42,95629 claims
AbbVieLinzess, Synthroid$1,076$31,19474 claims
GSKTrelegy Ellipta$105$27,88927 claims
Astellas Pharma US IncMyrbetriq$389$15,65013 claims
NovartisEntresto$374$7,96313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Pooler

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →